- Home
- IROQ vs SRZN Comparison
IROQ vs SRZN Comparison
Compare IROQ & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IROQ
- SRZN
- Stock Information
- Founded
- IROQ 1883
- SRZN 2015
- Country
- IROQ United States
- SRZN United States
- Employees
- IROQ N/A
- SRZN N/A
- Industry
- IROQ Savings Institutions
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- IROQ Finance
- SRZN Health Care
- Exchange
- IROQ Nasdaq
- SRZN Nasdaq
- Market Cap
- IROQ 75.8M
- SRZN 82.8M
- IPO Year
- IROQ 2011
- SRZN N/A
- Fundamental
- Price
- IROQ $23.96
- SRZN $8.35
- Analyst Decision
- IROQ
- SRZN Strong Buy
- Analyst Count
- IROQ 0
- SRZN 2
- Target Price
- IROQ N/A
- SRZN $38.50
- AVG Volume (30 Days)
- IROQ 1.1K
- SRZN 10.4K
- Earning Date
- IROQ 04-29-2025
- SRZN 05-20-2025
- Dividend Yield
- IROQ 1.66%
- SRZN N/A
- EPS Growth
- IROQ 69.23
- SRZN N/A
- EPS
- IROQ 1.05
- SRZN N/A
- Revenue
- IROQ $25,099,000.00
- SRZN $10,655,000.00
- Revenue This Year
- IROQ N/A
- SRZN N/A
- Revenue Next Year
- IROQ N/A
- SRZN N/A
- P/E Ratio
- IROQ $23.01
- SRZN N/A
- Revenue Growth
- IROQ 12.02
- SRZN N/A
- 52 Week Low
- IROQ $14.85
- SRZN $6.00
- 52 Week High
- IROQ $25.76
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- IROQ 50.35
- SRZN 33.48
- Support Level
- IROQ $23.80
- SRZN $9.96
- Resistance Level
- IROQ $24.46
- SRZN $11.56
- Average True Range (ATR)
- IROQ 0.18
- SRZN 0.72
- MACD
- IROQ 0.03
- SRZN -0.13
- Stochastic Oscillator
- IROQ 58.78
- SRZN 1.53
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).